Zhang Xuan-Hao, Li Ying, Jin Cheng-Yu, Zhang Jia-Le, Yan Yang-Peng, Guo Jia-Xiu, Lu Xin, Pang Han-Qing, Zhao Yong-Juan
Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou, 225009, People's Republic of China.
Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225009, People's Republic of China.
Mol Biol Rep. 2025 Jun 7;52(1):568. doi: 10.1007/s11033-025-10667-0.
Within minutes of an ischemic stroke, mitochondrial dysfunction and energy metabolism disorders occur. This leads to a sustained release of glutamate and an overload of intracellular calcium. An increase in intracellular Ca leads to an excessive production of ROS, which in turn activates inflammatory responses. IR leads to the succinate metabolism, which causes an imbalance in the redox state. This imbalance can trigger a series of cascade reactions that may lead to the death of damaged neurons and the leakage of the blood-brain barrier. During IR, the disruption of key enzymes and metabolic intermediates is crucial in exacerbating mitochondrial dysfunction. Mitochondrial dysfunction in ischemic stroke involves a complex network of metabolic pathways, including glutamate metabolism, succinate metabolism, and fatty acid metabolism. This complexity lays the groundwork for creating new therapeutic strategies. Several natural products, such as EGb761, tanshinones, and notoginsenosides, have shown promising effects in regulating mitochondrial metabolism, which has the potential to restore energy production, thereby alleviating oxidative stress. This review systematically summarized the multi-target mechanisms of ischemic stroke from the aspect of mitochondrial metabolism. And the clinical applications of natural products against ischemic stroke were also reviewed. Future research should aim to clarify how natural products can treat ischemic stroke by influencing mitochondrial pathways.
在缺血性中风发生后的几分钟内,线粒体功能障碍和能量代谢紊乱就会出现。这会导致谷氨酸持续释放以及细胞内钙超载。细胞内钙的增加会导致活性氧(ROS)过度产生,进而激活炎症反应。缺血再灌注(IR)会导致琥珀酸代谢,引起氧化还原状态失衡。这种失衡会引发一系列级联反应,可能导致受损神经元死亡和血脑屏障渗漏。在缺血再灌注期间,关键酶和代谢中间体的破坏对加剧线粒体功能障碍至关重要。缺血性中风中的线粒体功能障碍涉及一个复杂的代谢途径网络,包括谷氨酸代谢、琥珀酸代谢和脂肪酸代谢。这种复杂性为制定新的治疗策略奠定了基础。几种天然产物,如银杏叶提取物EGb761、丹参酮和三七总皂苷,在调节线粒体代谢方面已显示出有前景的效果,这有可能恢复能量产生,从而减轻氧化应激。本综述从线粒体代谢方面系统总结了缺血性中风的多靶点机制。同时也综述了天然产物在抗缺血性中风方面的临床应用。未来的研究应旨在阐明天然产物如何通过影响线粒体途径来治疗缺血性中风。